# Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI)

Study · id `cardio:ct-nct06898086` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06898086](<https://clinicaltrials.gov/study/NCT06898086>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06898086

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 620 participants.

## Technical summary

Registry record NCT06898086. Randomized; no masking; primary purpose treatment. Start 2025-08-08 (actual); primary completion 2028-05-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 620 participants (planned count; ClinicalTrials.gov record NCT06898086, source copy `cardio:ctgov-nct06898086-2026-08-25`, retrieved 2026-10-26)
- Started: 2025-08-08 (actual) (ClinicalTrials.gov record NCT06898086, source copy `cardio:ctgov-nct06898086-2026-08-25`, retrieved 2026-10-26)
- Primary completion: 2028-05-31 (anticipated) (ClinicalTrials.gov record NCT06898086, source copy `cardio:ctgov-nct06898086-2026-08-25`, retrieved 2026-10-26)
- Completion: 2029-05-31 (anticipated) (ClinicalTrials.gov record NCT06898086, source copy `cardio:ctgov-nct06898086-2026-08-25`, retrieved 2026-10-26)
- Countries: Austria; Czechia; France; Germany; Italy; Netherlands; Switzerland (ClinicalTrials.gov record NCT06898086, source copy `cardio:ctgov-nct06898086-2026-08-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ENROLLING\_BY\_INVITATION" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06898086-2026-08-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI)
- Acronym: PURETAVI
- Condition: Severe Aortic Stenosis
- Intervention (Device): Transcatheter aortic valve implantation
- Lead sponsor: Rede Optimus Hospitalar SA
- Lead sponsor class: NETWORK
- Collaborator: Meril Life Sciences Pvt. Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Rede Optimus Hospitalar SA (`cardio:org-rede-optimus-hospitalar-sa`)
- Registry lists this organization as a collaborator: Meril Life Sciences Pvt. Ltd. (`cardio:org-meril-life-sciences-pvt-ltd`)

## Provenance

Content hash: 8fda13cec014c7b2048395c7f793de8d8d597a5f6d4434a76f1ef42abaff3055
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
